BioSpace News Archive

Exo Therapeutics, Inc. today announced the appointment of Laura Kiessling, PhD, to the company’s Scientific Advisory Board (SAB).

Mednow Inc. is pleased to provide a corporate update on its upcoming fiscal Q3 2022 quarterly earnings, which will be released in June 2022.

According to the report, the global active pharmaceutical ingredients market was valued at US$ 168 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

The healthcare packaging market is anticipated to grow extensively across the assessment period of 2020-2030.

Albany NY, United States: During the peak of the coronavirus outbreak amid the second wave in India, there had been an unprecedented demand for Remdesivir - an antiviral medication for the treatment of patients.

Albany NY, United States: According to the report, the global short bowel syndrome market was valued at US$ 728.3 Mn in 2020 and is projected to expand at a CAGR of 15.9% from 2021 to 2031.

Midatech Pharma PLC announces its audited preliminary results for the year ended 31 December 2021.

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that fourteen abstracts related to Aerie’s Rhopressa®/netarsudil, AR-15512 in dry eye and “ROCK’Sters” anti-inflammatory programs will be presented at the Association for Research in Vision and Ophthalmology Annual Meeting.

Senseonics Holdings, Inc. announced that it plans to release its first quarter 2022 financial results after market close on Tuesday, May 10, 2022.

Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, today provided a corporate update and reported financial results for the full year ended December 31, 2021.